Boston Financial Mangement LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Boston Financial Mangement LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,705 shares of the medical equipment provider’s stock after selling 127 shares during the quarter. Boston Financial Mangement LLC’s holdings in Intuitive Surgical were worth $1,934,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Concurrent Investment Advisors LLC grew its position in shares of Intuitive Surgical by 23.0% in the fourth quarter. Concurrent Investment Advisors LLC now owns 12,145 shares of the medical equipment provider’s stock valued at $6,339,000 after purchasing an additional 2,272 shares during the last quarter. Meitav Investment House Ltd. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $209,000. Handelsbanken Fonder AB boosted its position in Intuitive Surgical by 32.8% during the fourth quarter. Handelsbanken Fonder AB now owns 255,743 shares of the medical equipment provider’s stock worth $133,488,000 after acquiring an additional 63,201 shares during the last quarter. Mcdaniel Terry & Co. boosted its position in Intuitive Surgical by 0.5% during the fourth quarter. Mcdaniel Terry & Co. now owns 70,499 shares of the medical equipment provider’s stock worth $36,798,000 after acquiring an additional 334 shares during the last quarter. Finally, Private Wealth Partners LLC boosted its position in Intuitive Surgical by 6.4% during the fourth quarter. Private Wealth Partners LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 87 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Piper Sandler restated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Down 0.3 %

Shares of ISRG stock opened at $606.57 on Friday. The company’s fifty day simple moving average is $564.41 and its 200-day simple moving average is $523.46. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $216.05 billion, a PE ratio of 94.63, a P/E/G ratio of 5.79 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.